Modicus Prime

📍 La Porte, United States🗓 Founded 2020👥 7 employees💰 Last funded 2022
Pharmaceutical Manufacturing🌐 modicusprime.com
Website LinkedIn
Modicus Prime's Self-Service software places cutting-edge AI where it belongs: in the hands of biotechnology experts. Our computer vision solution, mpVision, provides intelligent image analysis to monitor biologics at any scale. mpVision has been tested by scientists in a Top 10 Pharma company supporting our mission to eliminate contamination from the pharmaceutical industry. These contaminations cost 100’s of millions of dollars per incident as illustrated by the recent Covid vaccine 60 M incident experienced by J&J/AstraZeneca/Emergent. Such unmet needs of the Life Sciences industry, including real-time product quality assurance, full agency compliance, faster go-to-market, and reduced operating costs, are being met with Modicus Prime’s Self-Service AI solution.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Modicus Prime?
Modicus Prime has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Modicus Prime last raise funding?
The most recent investment in Modicus Prime recorded on gritt.io was in 2022.
When was Modicus Prime founded?
Modicus Prime was founded in 2020.
What industry is Modicus Prime in?
Modicus Prime operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Modicus Prime based?
Modicus Prime is headquartered in La Porte, United States.